HAFLONE PLUS

This brand name is authorized in Nigeria.

Active ingredients

The drug HAFLONE PLUS contains a combination of these active pharmaceutical ingredients (APIs):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone
2	Sulbactam UNII DKQ4T82YE6 - SULBACTAM SODIUM
	Read more about Sulbactam

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5443	Injection	Haflone Plus Injection INJ 1000 mg; 500 mg 1 x 1's, 1 x 5's, 1 x 10's, 1 x 25's, 1 x 50's (in 2 mL vials)	Powder for Solution for Injection or Infusion HAFLONE PLUS INJECTION B4-5443 HAFLONE PLUS INJECTION CEFTRIAXONE 1GRAM, SULBACTAM 500MG Q.S Injection Prescription Only Medicine (POM) HANBET PHARMACEUTICALS LIMITED, , MURTALA MOHAMMED WAY, EBUTE-METTA LAGOS Nigeria NCPC HEBEI HUAMIN PHARM. CO.LTD., NO. 98 HAINAN ROAD, ECONOMIC TECH DEV. ZONE SHIJIAZHUANG, CHINA, China 1/26/2023 1/25/2028	26/01/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD04	Ceftriaxone	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5443